|
|
|
Insider
Information: |
Cohen Fred E |
Relationship: |
|
City: |
San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
9 |
|
Direct
Shares |
366,218 |
|
Indirect Shares
|
4,593,263 |
|
|
Direct
Value |
$4,914,499 |
|
|
Indirect Value
|
$60,038,108 |
|
|
Total
Shares |
4,959,481 |
|
|
Total
Value |
$64,952,607 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
Percentage
Gain/Loss : |
0.0%
|
216.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Genomic Health Inc |
GHDX |
Director |
2019-11-08 |
0 |
2019-11-08 |
0 |
Premium* |
|
Five Prime Therapeutics Inc |
FPRX |
Director |
2016-01-11 |
24,807 |
2014-07-01 |
0 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2017-09-18 |
119,410 |
2014-08-29 |
0 |
Premium* |
|
Caredx, Inc. |
CDNA |
Director |
2023-06-16 |
132,592 |
2014-10-01 |
0 |
Premium* |
|
Intellia Therapeutics, Inc. |
NTLA |
Director |
2023-06-14 |
41,716 |
2019-03-01 |
0 |
Premium* |
|
Urogen Pharma Ltd. |
URGN |
Director |
2019-02-06 |
15,000 |
2023-07-26 |
69,339 |
Premium* |
|
Veracyte, Inc. |
VCYT |
Director |
2020-10-19 |
10,000 |
2019-08-02 |
0 |
Premium* |
|
Progyny, Inc. |
PGNY |
Director |
2024-05-23 |
22,693 |
2020-10-24 |
0 |
Premium* |
|
Kyverna Therapeutics |
KYTX |
|
2024-02-12 |
0 |
2024-02-12 |
4,523,924 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
117 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GHDX |
Genomic Health Inc |
Director |
|
2005-09-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,333 |
|
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2005-09-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,833 |
|
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2005-10-04 |
4 |
A |
$0.00 |
$0 |
D/D |
33,333 |
43,351 |
|
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2008-02-19 |
4 |
OE |
$0.58 |
$3,000 |
D/D |
5,201 |
48,552 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-12-09 |
5 |
A |
$0.00 |
$0 |
D/D |
133 |
48,685 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-04-01 |
4 |
A |
$24.60 |
$9,988 |
D/D |
406 |
49,091 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-07-01 |
4 |
A |
$27.91 |
$9,992 |
D/D |
358 |
49,449 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-10-01 |
4 |
A |
$21.98 |
$9,979 |
D/D |
454 |
49,903 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-11-04 |
4 |
A |
$0.00 |
$0 |
D/D |
131 |
50,035 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-01-01 |
4 |
A |
$25.39 |
$9,978 |
D/D |
393 |
50,427 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-04-01 |
4 |
A |
$30.61 |
$9,979 |
D/D |
326 |
50,753 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-07-01 |
4 |
A |
$33.40 |
$9,987 |
D/D |
299 |
51,052 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-08-01 |
4 |
OE |
$10.73 |
$88,523 |
D/D |
8,250 |
59,302 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-10-01 |
4 |
A |
$35.89 |
$10,336 |
D/D |
288 |
59,590 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2013-01-01 |
4 |
A |
$27.24 |
$9,997 |
D/D |
367 |
59,957 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2013-04-01 |
4 |
A |
$27.99 |
$9,992 |
D/D |
357 |
60,314 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2013-07-01 |
4 |
A |
$32.85 |
$9,954 |
D/D |
303 |
60,617 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2013-10-01 |
4 |
A |
$30.33 |
$9,979 |
D/D |
329 |
60,946 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2014-01-01 |
4 |
A |
$29.27 |
$9,981 |
D/D |
341 |
61,287 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2014-04-01 |
4 |
A |
$26.57 |
$9,990 |
D/D |
376 |
61,663 |
0 |
- |
|
FPRX |
Five Prime Therapeutics I... |
Director |
|
2014-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
112 |
112 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2014-07-01 |
4 |
A |
$27.86 |
$9,974 |
D/D |
358 |
62,021 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2014-08-29 |
4 |
A |
$13.50 |
$8,748 |
D/D |
648 |
648 |
0 |
- |
|
CDNA |
Caredx, Inc. |
Director |
|
2014-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
658 |
658 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2014-10-01 |
4 |
A |
$28.54 |
$9,989 |
D/D |
350 |
62,371 |
0 |
- |
|
117 Records found
|
|
Page 1 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|